Roshan Girglani
Verkoop & Marketing bij MILESTONE PHARMACEUTICALS INC.
Oorsprong van het eerstegraads netwerk van Roshan Girglani
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 17 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Roshan Girglani via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
University of Wisconsin | College/University | Undergraduate Degree Graduate Degree | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer Treasurer | |
GENMARK DIAGNOSTICS, INC. | Medical Specialties | Director/Board Member | |
DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
HCW BIOLOGICS INC. | Biotechnology | Director/Board Member | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
Art Institute of Chicago | College/University | Director/Board Member | |
G.D. Searle LLC | Corporate Officer/Principal | ||
Giles & Associates Consultancy
Giles & Associates Consultancy Miscellaneous Commercial ServicesCommercial Services Giles & Associates Consultancy provides management consulting services for the healthcare industry. The private company is based in Lake Bluff, IL. The company was founded by Lisa M. Giles. Lisa M. Giles has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
Ortho-McNeil Pharmaceutical LLC
Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Chairman | |
Optivara, Inc. | Chief Executive Officer | ||
Université Paris III Sorbonne Nouvelle | College/University | Doctorate Degree | |
Juniata College | College/University | Undergraduate Degree | |
Northwestern Memorial Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Cimeio Therapeutics AG
Cimeio Therapeutics AG Packaged SoftwareTechnology Services Cimeio Therapeutics AG is an applied gene editing and immunotherapy company based in Basel, Switzerland. Cimeio is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip) that have the potential to transform hematopoietic stem cell transplant. The Swiss company's technology platform is based on the design and expression of modified variants of naturally occurring cell surface proteins in hscs. These novel variants maintain their function but are resistant to depletion when targeted by a paired immunotherapy which has high affinity for the wild-type version of these proteins. Cimeio is the leader of the field of epitope editing and is developing a portfolio of shielded-cell & immunotherapy pairs™ (scip), novel immunotherapies which have the potential to transform treatment of hematologic diseases. The company develops state-of-the-art immunotherapies, along with paired, modified variants of naturally occurring cell surface proteins in hscs. These immunotherapies have significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with hematologic malignancies, autoimmune disorders, and genetic diseases. The company was founded by Lukas Jeker and the CEO is Thomas Fuchs. | Packaged Software | Director/Board Member | |
ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
CRISPR THERAPEUTICS AG | Biotechnology | Director of Finance/CFO | |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Part of The Ensign Group, Inc., The Lexington operates a 125-bed assisted living facility. The company is based in Ventura, CA. | Medical/Nursing Services | Director of Finance/CFO | |
ABIOMED, INC. | Medical Specialties | Director of Finance/CFO | |
Motorola Automotive & Industrial Electronics Group | Corporate Officer/Principal | ||
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services General Electric Healthcare Technologies, Inc. provides transformational medical technologies and services. The company is headquartered in Houston, TX. | Medical/Nursing Services | Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CYMABAY THERAPEUTICS, INC. | Biotechnology | Chairman | |
FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Messiah | College/University | Undergraduate Degree | |
Wilmington University | College/University | Graduate Degree | |
Salve Regina University | College/University | Undergraduate Degree | |
Rensselaer Polytechnic Institute | College/University | Graduate Degree | |
INSMED INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
BIOXCEL THERAPEUTICS, INC. | Biotechnology | Human Resources Officer | |
ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Haverford College | College/University | Undergraduate Degree | |
The University of Chicago | College/University | Doctorate Degree | |
SANOFI | Biotechnology | Corporate Officer/Principal | |
The Leonard N Stern School of Business | College/University | Masters Business Admin | |
The University of Texas at Austin | College/University | Doctorate Degree | |
Drexel University | College/University | Undergraduate Degree | |
Brandeis University | College/University | Undergraduate Degree | |
AXSOME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Feldan Bio, Inc. develops, produces and supplies recombinant proteins for therapeutic and research purposes. It specializes in cell culture products, cytokines, enzymes, receptors, clinical grade cytokines, and research proteins. The company was founded by Fran?ois-Thomas Michaud and Francois-Eric Lebeau in 2007 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 42 |
Zwitserland | 4 |
Frankrijk | 3 |
Japan | 2 |
Ierland | 2 |
Sectoraal
Health Technology | 28 |
Consumer Services | 15 |
Health Services | 3 |
Commercial Services | 2 |
Miscellaneous | 2 |
Operationeel
Director/Board Member | 39 |
Corporate Officer/Principal | 30 |
Independent Dir/Board Member | 16 |
Undergraduate Degree | 13 |
Chairman | 11 |
Sterkste connecties
Insiders | |
---|---|
Seth Fischer | 17 |
Richard Pasternak | 16 |
Robert Wills | 13 |
Debra Liebert | 12 |
Michael Tomsicek | 12 |
Lisa Giles | 12 |
Joseph Oliveto | 7 |
Amit Hasija | 7 |
Lorenz Muller | 6 |
Francis Plat | 6 |
Guy Rousseau | 5 |
Kimberly Sheehan | 5 |
Jeff Nelson | 4 |
David Bharucha | 4 |
Anita Holz | 4 |
- Beurs
- Insiders
- Roshan Girglani
- Bedrijfsconnecties